1 EXECUTIVE SUMMARY
1.1 OVERVIEW
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 GROWING PREFERENCE FOR HEALTHCARE COST OPTIMIZATION
4.2.2 INCREASING NEED TO IMPROVE DIAGNOSIS AND TREATMENT PLANNING
4.2.3 INCREASING NUMBER OF CANCER CASES
4.3 RESTRAINTS
4.3.1 HIGH COST OF MEDICAL SECOND OPINION
4.3.2 LACK OF AWARENESS AMONG PEOPLE
4.4 OPPORTUNITIES
4.4.1 RISING NUMBER OF STRATEGIC INITIATIVES
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 R&D
5.1.2 SERVICE
5.1.3 SALES AND MARKETING
5.1.4 CONTRACT MANAGEMENT
5.1.5 CUSTOMER SERVICE & SUPPORT
5.2 PORTER'S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT OF SUBSTITUTES
5.2.4 BARGAINING POWER OF BUYERS
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE US MEDICAL SECOND OPINION MARKET
5.3.1 IMPACT ON VALUE CHAIN
5.3.2 IMPACT ON DEMAND
5.3.3 IMPACT ON REGION
5.3.4 IMPACT ON KEY PLAYERS
6 US MEDICAL SECOND OPINION MARKET, BY DIAGNOSIS
6.1 OVERVIEW
6.2 CANCER
6.3 CARDIOVASCULAR/HEART DISORDERS
6.4 SPINE PROCEDURES
6.5 NEUROLOGY CONDITIONS
6.6 OTHERS
7 US MEDICAL SECOND OPINION MARKET, BY SERVICE PROVIDER
7.1 OVERVIEW
7.2 HOSPITALS PHYSICIANS/SPECIALTIES
7.3 ONLINE PHYSICIANS PORTAL
7.4 MEDICAL SECOND OPINION COMPANIES
7.5 HEALTH INSURANCE COMPANIES
8 US MEDICAL SECOND OPINION MARKET, BY MODE OF PAYMENT
8.1 OVERVIEW
8.2 ONLINE PAYMENT
8.3 OFFLINE PAYMENT
9 COMPANY PROFILES
9.1 SECONDOPINIONEXPERT, INC.
9.1.1 COMPANY OVERVIEW
9.1.2 FINANCIAL OVERVIEW
9.1.3 PRODUCTS OFFERED
9.1.4 KEY DEVELOPMENTS
9.1.5 SWOT ANALYSIS
9.1.6 KEY STRATEGIES
9.2 INCLUDED HEALTH, INC.
9.2.1 COMPANY OVERVIEW
9.2.2 FINANCIAL OVERVIEW
9.2.3 PRODUCTS OFFERED
9.2.4 KEY DEVELOPMENTS
9.2.5 SWOT ANALYSIS
9.2.6 KEY STRATEGIES
9.3 ACCESSHOPE, LLC
9.3.1 COMPANY OVERVIEW
9.3.2 FINANCIAL OVERVIEW
9.3.3 PRODUCTS OFFERED
9.3.4 KEY DEVELOPMENTS
9.3.5 SWOT ANALYSIS
9.3.6 KEY STRATEGIES
9.4 NAVVISA
9.4.1 COMPANY OVERVIEW
9.4.2 FINANCIAL OVERVIEW
9.4.3 SERVICES OFFERED
9.4.4 KEY DEVELOPMENTS
9.4.5 KEY STRATEGIES
9.5 2ND.MD
9.5.1 COMPANY OVERVIEW
9.5.2 FINANCIAL OVERVIEW
9.5.3 SERVICES OFFERED
9.5.4 SWOT ANALYSIS
9.5.5 KEY DEVELOPMENTS
9.5.6 KEY STRATEGIES
10 APPENDIX
10.1 REFERENCES
10.2 RELATED REPORTS
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
TABLE 1 US: MEDICAL SECOND OPINION MARKET, BY DIAGNOSIS, 2018–2030 (USD MILLION)
TABLE 2 US: MEDICAL SECOND OPINION MARKET, FOR CANCER, BY TYPE, 2018–2030 (USD MILLION)
TABLE 3 US: MEDICAL SECOND OPINION MARKET, FOR CARDIOVASCULAR/HEART DISORDERS, BY TYPE, 2018–2030 (USD MILLION)
TABLE 4 US: MEDICAL SECOND OPINION MARKET, FOR SPINE PROCEDURES, BY TYPE, 2018–2030 (USD MILLION)
TABLE 5 US: MEDICAL SECOND OPINION MARKET, FOR NEUROLOGY CONDITIONS, BY TYPE, 2018–2030 (USD MILLION)
TABLE 6 US: MEDICAL SECOND OPINION MARKET, BY SERVICE PROVIDER, 2018–2030 (USD MILLION)
TABLE 7 US: MEDICAL SECOND OPINION MARKET, BY MODE OF PAYMENT, 2018–2030 (USD MILLION)
TABLE 8 SECONDOPINIONEXPERT, INC.: SERVICES OFFERED
TABLE 9 INCLUDED HEALTH, INC.: SERVICES OFFERED
TABLE 10 INCLUDED HEALTH, INC.: KEY DEVELOPMENTS
TABLE 11 ACCESSHOPE, LLC: SERVICES OFFERED
TABLE 12 ACCESSHOPE, LLC: KEY DEVELOPMENTS
TABLE 13 NAVVISA: SERVICES OFFERED
TABLE 14 2ND.MD: SERVICES OFFERED
LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS
FIGURE 2 US MEDICAL SECOND OPINION MARKET
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE US MEDICAL SECOND OPINION MARKET
FIGURE 5 DRIVER IMPACT ANALYSIS
FIGURE 6 RESTRAINT IMPACT ANALYSIS
FIGURE 7 VALUE CHAIN ANALYSIS: US MEDICAL SECOND OPINION MARKET
FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: US MEDICAL SECOND OPINION MARKET
FIGURE 9 US: MEDICAL SECOND OPINION MARKET, BY DIAGNOSIS, 2021 & 2030 (USD MILLION)
FIGURE 10 US: MEDICAL SECOND OPINION MARKET, BY SERVICE PROVIDER, 2021 & 2030 (USD MILLION)
FIGURE 11 US: MEDICAL SECOND OPINION MARKET, BY MODE OF PAYMENT, 2021 & 2030 (USD MILLION)
FIGURE 12 SECONDOPINIONEXPERT, INC.: SWOT ANALYSIS
FIGURE 13 INCLUDED HEALTH, INC.: SWOT ANALYSIS
FIGURE 14 ACCESSHOPE, LLC: SWOT ANALYSIS
FIGURE 15 2ND.MD: SWOT ANALYSIS
LIST OF ABBREVIATION
Abbreviation Full Form
US United States
CAGR Compound Annual Growth Rate